Immunolesioning of nerve growth factor p75 receptor-containing neurons in the rat brain by a novel immunotoxin : anti-p75-anti-mouse IgG-trichosanthin conjugates

In the present study, a comparison of potency between a commercially available immunotoxin, 192-immunoglobulin-SAP (192-IgG), and a novel immunotoxin produced in our laboratory, anti-p75-anti-mouse IgG-trichosanthin conjugates (p75-TCS), was conducted. Both of the immunotoxins were specific for nerve growth factor p75 receptor. Cholinergic neurons in the rat basal forebrain and in the neostriatum were depleted after the injection of either 192-IgG or p75-TCS. These indicate that both types of immunotoxins are potent and useful in performing immunolesioning experiments. In addition, there were variations in potency among the two immunotoxins in different routes of administration. The 192-IgG was more potent than the p75-TCS in the case of ventricular injections. In case of striatal injections, 192-IgG caused serious tissue necrosis and considerable tissue damage in the brain region. In contrast, p75-TCS was potent and caused a selective and specific depletion of cholinergic neurons in the neostriatum. These results indicate that indirect immunotoxins may be more useful for performing immunolesioning experiments in case of brain parenchyma administration.

Medienart:

Artikel

Erscheinungsjahr:

1999

Erschienen:

1999

Enthalten in:

Zur Gesamtaufnahme - volume:846

Enthalten in:

Brain research - 846(1999), 2 vom: 06. Nov., Seite 154-63

Sprache:

Englisch

Beteiligte Personen:

Kwok, K H [VerfasserIn]
Law, K B [VerfasserIn]
Wong, R N [VerfasserIn]
Yung, K K [VerfasserIn]

Themen:

192 IgG-saporin
60318-52-7
Antibodies, Monoclonal
Antineoplastic Agents, Phytogenic
Choline O-Acetyltransferase
Cholinergic Agents
Comparative Study
EC 2.3.1.6
EC 3.2.2.-
EC 3.2.2.22
Immunoglobulin G
Immunotoxins
Journal Article
N-Glycosyl Hydrolases
Receptor, Nerve Growth Factor
Research Support, Non-U.S. Gov't
Ribosome Inactivating Proteins, Type 1
Saporins
Trichosanthin

Anmerkungen:

Date Completed 10.12.1999

Date Revised 14.06.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM104868988